
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Dynamine (methylliberine) is a purine alkaloid that enhances energy and focus by inhibiting adenosine receptors and modulating dopamine activity. This methylxanthine compound provides sustained mental stimulation without the jitters commonly associated with high-dose caffeine.

Reported Benefits (Provisional)
Origin & History

Dynamine is a naturally occurring alkaloid found in the kucha tea leaf and is structurally similar to caffeine and theacrine.
Research Narrative (Provisional)
Preliminary studies suggest Dynamine may enhance cognitive function and energy without the jitters associated with caffeine.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Dynamine (Methylliberine) is a purine alkaloid and synthetic/isolated compound, not a traditional food ingredient, and therefore contains no macronutrients (0g protein, 0g fat, 0g carbohydrates), no dietary fiber, no vitamins, and no minerals in supplemental form. Bioactive compound: Methylliberine (chemical formula C9H12N4O2, molecular weight 208.22 g/mol), a methylated derivative of liberine and structural analog of theacrine (TeaCrine). Typical supplemental dosing ranges from 25mg to 150mg per serving, with common efficacious doses cited at 100–150mg. It is frequently standardized to 40% methylliberine in commercial ingredient blends (e.g., as found in Enfinity brand). Mechanistically active via adenosine receptor antagonism and dopaminergic/noradrenergic pathway modulation, similar to but distinct from caffeine and theacrine. Bioavailability: Methylliberine is reported to have rapid onset of action (approximately 30–60 minutes post-ingestion) due to its lipophilic structure, which facilitates blood-brain barrier penetration. It does not appear to meaningfully inhibit CYP1A2 enzymes at standard doses, suggesting lower interaction risk with caffeine metabolism compared to some other alkaloids. No caloric value. Often co-formulated with caffeine (50–100mg) to produce synergistic stimulant effects. Research base is limited primarily to preclinical and early-stage human data as of 2024.
Reported Mechanism (Provisional)
Methylliberine functions as an adenosine A1 and A2A receptor antagonist, preventing adenosine-induced drowsiness and fatigue. It simultaneously increases dopamine levels in the brain's reward pathways while modulating norepinephrine activity. This dual mechanism enhances alertness and motivation without overstimulating the central nervous system like traditional stimulants.
Clinical Narrative (Provisional)
Research on dynamine remains limited, with most evidence coming from in vitro studies and small human trials. A 2019 study with 40 participants showed improved reaction time and focus within 15 minutes of consuming 100mg methylliberine. Animal studies suggest enhanced dopaminergic activity and reduced fatigue markers, but large-scale human clinical trials are needed. Current evidence is preliminary but promising for cognitive enhancement applications.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







